Adrian J. Mogg

2.0k total citations
27 papers, 1.5k citations indexed

About

Adrian J. Mogg is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Sensory Systems. According to data from OpenAlex, Adrian J. Mogg has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 6 papers in Sensory Systems. Recurrent topics in Adrian J. Mogg's work include Receptor Mechanisms and Signaling (14 papers), Nicotinic Acetylcholine Receptors Study (13 papers) and Neuroscience and Neuropharmacology Research (9 papers). Adrian J. Mogg is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Nicotinic Acetylcholine Receptors Study (13 papers) and Neuroscience and Neuropharmacology Research (9 papers). Adrian J. Mogg collaborates with scholars based in United Kingdom, United States and Australia. Adrian J. Mogg's co-authors include Susan Wonnacott, Lisa M. Broad, Federico Dajas‐Bailador, Christian C. Felder, Ian W. Jones, L. Soliakov, Sergio Kaiser, Helen Sanger, Allan C. Collins and Michael J. Marks and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Neurochemistry.

In The Last Decade

Adrian J. Mogg

27 papers receiving 1.5k citations

Peers

Adrian J. Mogg
Adrian J. Mogg
Citations per year, relative to Adrian J. Mogg Adrian J. Mogg (= 1×) peers Paolo Ambrosino

Countries citing papers authored by Adrian J. Mogg

Since Specialization
Citations

This map shows the geographic impact of Adrian J. Mogg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian J. Mogg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian J. Mogg more than expected).

Fields of papers citing papers by Adrian J. Mogg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian J. Mogg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian J. Mogg. The network helps show where Adrian J. Mogg may publish in the future.

Co-authorship network of co-authors of Adrian J. Mogg

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian J. Mogg. A scholar is included among the top collaborators of Adrian J. Mogg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian J. Mogg. Adrian J. Mogg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allison, Matthew, et al.. (2024). Discovery of α-Amidobenzylboronates as Highly Potent Covalent Inhibitors of Plasma Kallikrein. ACS Medicinal Chemistry Letters. 15(4). 501–509. 2 indexed citations
2.
Felder, Christian C., Paul Goldsmith, Kimberley Jackson, et al.. (2018). Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases. Neuropharmacology. 136(Pt C). 449–458. 64 indexed citations
3.
Mogg, Adrian J., Thomas E. Eessalu, Megan Johnson, et al.. (2018). In Vitro Pharmacological Characterization and In Vivo Validation of LSN3172176 a Novel M1 Selective Muscarinic Receptor Agonist Tracer Molecule for Positron Emission Tomography. Journal of Pharmacology and Experimental Therapeutics. 365(3). 602–613. 8 indexed citations
4.
Bradley, Sophie J., Colin Molloy, Christoffer Bundgaard, et al.. (2018). Bitopic Binding Mode of an M1 Muscarinic Acetylcholine Receptor Agonist Associated with Adverse Clinical Trial Outcomes. Molecular Pharmacology. 93(6). 645–656. 21 indexed citations
5.
Broad, Lisa M., Helen Sanger, Adrian J. Mogg, et al.. (2018). Identification and pharmacological profile of SPP1, a potent, functionally selective and brain penetrant agonist at muscarinic M 1 receptors. British Journal of Pharmacology. 176(1). 110–126. 9 indexed citations
6.
Butcher, Adrian J., Sophie J. Bradley, Rudi Prihandoko, et al.. (2016). An Antibody Biosensor Establishes the Activation of the M1 Muscarinic Acetylcholine Receptor during Learning and Memory. Journal of Biological Chemistry. 291(17). 8862–8875. 25 indexed citations
7.
Bakker, Geor, Kora de Bruin, Jos Eersels, et al.. (2015). 123I-Iododexetimide Preferentially Binds to the Muscarinic Receptor Subtype M1In Vivo. Journal of Nuclear Medicine. 56(2). 317–322. 18 indexed citations
8.
Pasqui, Francesca, Helen Sanger, Adrian J. Mogg, et al.. (2015). Activation of Muscarinic M1 Acetylcholine Receptors Induces Long-Term Potentiation in the Hippocampus. Cerebral Cortex. 26(1). 414–426. 112 indexed citations
9.
Dage, Jeffrey L., Antoine Fouillet, William C. Roell, et al.. (2014). Pharmacological characterisation of ligand- and voltage-gated ion channels expressed in human iPSC-derived forebrain neurons. Psychopharmacology. 231(6). 1105–1124. 43 indexed citations
10.
Grubisha, Olivera, Adrian J. Mogg, Helen Sanger, et al.. (2013). Pharmacological profiling of the TRPV3 channel in recombinant and native assays. British Journal of Pharmacology. 171(10). 2631–2644. 18 indexed citations
11.
Schuelert, Niklas, Adrian J. Mogg, Deena L. Hepburn, et al.. (2010). Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteoarthritic knee joint pain. Osteoarthritis and Cartilage. 18(11). 1536–1543. 67 indexed citations
12.
Filippi, Giovanna De, Adrian J. Mogg, Keith G. Phillips, et al.. (2010). The subtype-selective nicotinic acetylcholine receptor positive allosteric potentiator 2087101 differentially facilitates neurotransmission in the brain. European Journal of Pharmacology. 643(2-3). 218–224. 9 indexed citations
13.
Leach, Katie, Richard Loiacono, Christian C. Felder, et al.. (2009). Molecular Mechanisms of Action and In Vivo Validation of an M4 Muscarinic Acetylcholine Receptor Allosteric Modulator with Potential Antipsychotic Properties. Neuropsychopharmacology. 35(4). 855–869. 132 indexed citations
14.
Zwart, Ruud, Anna L. Carbone, Mirko Moroni, et al.. (2008). Sazetidine-A Is a Potent and Selective Agonist at Native and Recombinant α4β2 Nicotinic Acetylcholine Receptors. Molecular Pharmacology. 73(6). 1838–1843. 96 indexed citations
15.
Broad, Lisa M., et al.. (2008). TRP channels as emerging targets for pain therapeutics. Expert Opinion on Therapeutic Targets. 13(1). 69–81. 38 indexed citations
16.
Smith, Janice W., et al.. (2006). Ligands selective for α4β2 but not α3β4 or α7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat. Psychopharmacology. 190(2). 157–170. 88 indexed citations
17.
Mogg, Adrian J., et al.. (2004). Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-iodo-A-85380. Neuropharmacology. 47(6). 848–859. 30 indexed citations
18.
Dajas‐Bailador, Federico, Adrian J. Mogg, & Susan Wonnacott. (2002). Intracellular Ca2+ signals evoked by stimulation of nicotinic acetylcholine receptors in SH‐SY5Y cells: contribution of voltage‐operated Ca2+ channels and Ca2+ stores. Journal of Neurochemistry. 81(3). 606–614. 134 indexed citations
19.
Mogg, Adrian J., Paul Whiteaker, J. Michael McIntosh, et al.. (2002). Methyllycaconitine Is a Potent Antagonist of α-Conotoxin-MII-Sensitive Presynaptic Nicotinic Acetylcholine Receptors in Rat Striatum. Journal of Pharmacology and Experimental Therapeutics. 302(1). 197–204. 125 indexed citations
20.
Dajas‐Bailador, Federico, Adrian J. Mogg, & Susan Wonnacott. (2001). Contribution of intracellular stores to the increase in cytoplasmic calcium after nAChR activation in SH-SY5Y cells. The Society for Neuroscience Abstracts. 27(1). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026